Ignite Creation Date:
2024-05-06 @ 1:10 PM
Last Modification Date:
2024-10-26 @ 1:10 PM
Study NCT ID:
NCT03959891
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-04-16
First Post:
2019-05-15
Brief Title:
AKT Inhibitor Ipatasertib With Endocrine and CDK 46 Inhibitor for Patients With Metastatic Breast Cancer TAKTIC
Sponsor:
Massachusetts General Hospital
Organization:
Massachusetts General Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-05-30
Start Date Type:
ACTUAL
Primary Completion Date:
2022-12-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-12
Completion Date Type:
ESTIMATED
First Submit Date:
2019-05-15
First Submit QC Date:
May 21 2019
Study First Post Date:
2019-05-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-14
Last Update Post Date:
2024-04-16
Last Update Post Date Type:
ACTUAL